1. Home
  2. JHS vs MBOT Comparison

JHS vs MBOT Comparison

Compare JHS & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo John Hancock Income Securities Trust

JHS

John Hancock Income Securities Trust

N/A

Current Price

$10.43

Market Cap

126.9M

Sector

Finance

ML Signal

N/A

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

N/A

Current Price

$1.19

Market Cap

126.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JHS
MBOT
Founded
N/A
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.9M
126.9M
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
JHS
MBOT
Price
$10.43
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $6.33
AVG Volume (30 Days)
11.3K
★ 412.0K
Earning Date
01-01-0001
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 60.27
EPS
★ N/A
N/A
Revenue
N/A
★ $116,887.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$475.55
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.36
$1.22
52 Week High
$12.09
$3.46

Technical Indicators

Market Signals
Indicator
JHS
MBOT
Relative Strength Index (RSI) 22.35 23.56
Support Level N/A N/A
Resistance Level $11.01 $2.21
Average True Range (ATR) 0.08 0.06
MACD -0.01 -0.01
Stochastic Oscillator 0.00 2.03

Price Performance

Historical Comparison
JHS
MBOT

About JHS John Hancock Income Securities Trust

John Hancock Income Securities Trust is a United States-based closed-end diversified management investment company. Its main objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Share on Social Networks: